The VEGF-A variant -2578 A allele was significantly associated with an increased risk of clinical recurrence of prostate cancer and chronic myeloid leukemia [55, 56]. The gene discussed is VEGFA; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.